Cargando…

HPV and radiosensitivity of cervical cancer: a narrative review

BACKGROUND AND OBJECTIVE: Cervical cancer (CC), the most common gynecological malignancy, is divided into two categories: human papillomavirus-related [HPV positive (HPV+)] and non-HPV-related [HPV negative (HPV−)]. Compared with HPV− CC, HPV+ CC has better radiosensitivity and prognosis. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yue, Zou, Dongling, Guo, Mingfang, He, Misi, He, Hao, Li, Xiuying, Zheng, Qian, Li, Qiaoling, Mao, Zejia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843372/ https://www.ncbi.nlm.nih.gov/pubmed/36660629 http://dx.doi.org/10.21037/atm-22-5930

Ejemplares similares

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)
por: He, Misi, et al.
Publicado: (2023)

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer
por: Zou, Dongling, et al.
Publicado: (2021)

HPV-Negative Cervical Cancer: A Narrative Review
por: Arezzo, Francesca, et al.
Publicado: (2021)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes
por: Lindel, Katja, et al.
Publicado: (2012)

Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription
por: Zheng, Jing-Jie, et al.
Publicado: (2020)

Multi-omics characterization of silent and productive HPV integration in cervical cancer
por: Fan, Junpeng, et al.
Publicado: (2023)

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
por: Huang, Chun-Ming, et al.
Publicado: (2022)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
por: Yi, Baozhu, et al.
Publicado: (2022)

Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
por: Lin, Yanzhu, et al.
Publicado: (2019)

Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids
por: He, Misi, et al.
Publicado: (2016)

Clinical analysis of HPV58-positive cervical cancer
por: Chen, Mengjie, et al.
Publicado: (2020)

Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study
por: Yuan, Li, et al.
Publicado: (2023)

Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity
por: Wu, Shuying, et al.
Publicado: (2023)

Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth
por: Liu, Yuan, et al.
Publicado: (2017)

The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review
por: Pereira, Sandrine, et al.
Publicado: (2022)

miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway
por: Song, Lili, et al.
Publicado: (2015)

Assesment of normal tissue radiosensitivity in cervical tumors
por: Carvalho, Ana TS, et al.
Publicado: (2013)

PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer
por: Wu, Zhuna, et al.
Publicado: (2022)

miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer
por: Wang, Xia, et al.
Publicado: (2016)

Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China
por: Li, Huaping, et al.
Publicado: (2020)

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011)

Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
por: Hou, Xiaoxue, et al.
Publicado: (2022)

The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review
por: Liu, Changxing, et al.
Publicado: (2018)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways
por: Chen, Xiaona, et al.
Publicado: (2021)

HPV16 E6 enhances the radiosensitivity in HPV-positive human head and neck squamous cell carcinoma by regulating the miR-27a-3p/SMG1 axis
por: Long, Dan, et al.
Publicado: (2021)

Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines
por: Göttgens, Eva-Leonne, et al.
Publicado: (2021)

Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression
por: Liu, Hang, et al.
Publicado: (2022)

Role of metabolism in cancer cell radioresistance and radiosensitization methods
por: Tang, Le, et al.
Publicado: (2018)

Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China
por: Ning, Yu-e, et al.
Publicado: (2019)

The characteristics of HPV integration in cervical intraepithelial cells
por: Li, Weiping, et al.
Publicado: (2019)

The involvement of HPV in cervical oncogenesis
por: Mitran, Mihai, et al.
Publicado: (2013)

MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
por: Lin, Mao, et al.
Publicado: (2017)

The role of TLRs in cervical cancer with HPV infection: a review
por: Yang, Xiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nrvih1mkufmn5eqfkq458av3mj